Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction
- PMID: 24222351
- DOI: 10.2337/db13-0863
Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction
Abstract
Islet amyloid polypeptide (IAPP) aggregates to form amyloid fibrils in patients with type 2 diabetes and acts as a potent stimulus for interleukin (IL)-1β secretion by bone marrow-derived macrophages. We sought to determine the contribution of resident islet macrophages to IAPP-induced inflammation and β-cell dysfunction. In cultured islets, macrophages (F4/80(+)CD11b(+)CD11c(+) cells) were required for IAPP-induced mRNA expression of the proinflammatory cytokines IL-1β, tumor necrosis factor-α, and IL-6 and the anti-inflammatory cytokines IL-10 and IL-1 receptor antagonist. Moreover, IAPP-induced IL-1β synthesis and caspase-1 activation were detected in macrophages but not other islet cell types. Transgenic mice with β-cell human IAPP (hIAPP) expression had impaired glucose tolerance, elevated islet Il1b mRNA, and decreased Il10 and Il1rn expression following high-fat feeding. Islet macrophages were the major source of these transcripts and expressed increased cell surface Ly6C and CD11c in hIAPP transgenic mice. Clodronate liposome-mediated depletion of islet macrophages improved glucose tolerance and blocked proinflammatory gene expression in hIAPP-expressing mice, despite increasing the amount of islet amyloid. These data provide the first evidence that IAPP aggregates skew resident islet macrophages toward a proinflammatory phenotype and suggest a mechanism by which anti-inflammatory therapies may protect β-cells from IAPP-induced islet dysfunction.
Comment in
-
Amyloid and the macrophage: it's all about local production of IL-1β.Diabetes. 2014 May;63(5):1448-50. doi: 10.2337/db14-0003. Diabetes. 2014. PMID: 24757195 Free PMC article. No abstract available.
Similar articles
-
IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.J Immunol. 2011 Sep 1;187(5):2755-65. doi: 10.4049/jimmunol.1002854. Epub 2011 Aug 3. J Immunol. 2011. PMID: 21813778
-
Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.Diabetes Obes Metab. 2017 May;19(5):682-694. doi: 10.1111/dom.12873. Epub 2017 Feb 27. Diabetes Obes Metab. 2017. PMID: 28058779
-
Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.Mol Metab. 2020 Jul;37:100984. doi: 10.1016/j.molmet.2020.100984. Epub 2020 Mar 27. Mol Metab. 2020. PMID: 32229246 Free PMC article.
-
Macrophages, cytokines and beta-cell death in Type 2 diabetes.Biochem Soc Trans. 2008 Jun;36(Pt 3):340-2. doi: 10.1042/BST0360340. Biochem Soc Trans. 2008. PMID: 18481953 Review.
-
Human IAPP amyloidogenic properties and pancreatic β-cell death.Cell Calcium. 2014 Nov;56(5):416-27. doi: 10.1016/j.ceca.2014.08.011. Epub 2014 Aug 27. Cell Calcium. 2014. PMID: 25224501 Review.
Cited by
-
RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes.Mol Metab. 2024 Feb;80:101877. doi: 10.1016/j.molmet.2024.101877. Epub 2024 Jan 11. Mol Metab. 2024. PMID: 38218538 Free PMC article.
-
Low concentration IL-1β promotes islet amyloid formation by increasing hIAPP release from humanised mouse islets in vitro.Diabetologia. 2020 Nov;63(11):2385-2395. doi: 10.1007/s00125-020-05232-2. Epub 2020 Jul 29. Diabetologia. 2020. PMID: 32728889 Free PMC article.
-
IL-1beta promotes the age-associated decline of beta cell function.iScience. 2021 Oct 9;24(11):103250. doi: 10.1016/j.isci.2021.103250. eCollection 2021 Nov 19. iScience. 2021. PMID: 34746709 Free PMC article.
-
β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances.Metabolites. 2021 Nov 22;11(11):796. doi: 10.3390/metabo11110796. Metabolites. 2021. PMID: 34822454 Free PMC article. Review.
-
The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and exploiting common ground for novel amyloidosis therapies.Protein Sci. 2018 Jul;27(7):1166-1180. doi: 10.1002/pro.3425. Protein Sci. 2018. PMID: 29664151 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials